Pharming Group N.V. (PHAR)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	598	650	763	756	572	993
Market Cap Growth	-14.84%	-14.84%	0.93%	32.18%	-42.41%	-10.20%
Enterprise Value	540	608	728	702	554	963
Last Close Price	8.72	10.06	11.43	11.03	8.94	15.20
PE Ratio	-	-	-	55.27	35.75	26.30
PS Ratio	2.01	2.19	3.11	3.68	2.88	4.68
PB Ratio	2.70	2.93	3.49	3.69	2.96	5.41
P/TBV Ratio	4.04	4.04	5.17	5.82	5.23	10.47
P/FCF Ratio	-	-	35.85	21.10	12.57
P/OCF Ratio	-	-	33.66	15.11	11.87
EV/Sales Ratio	1.82	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	72.54	81.64	-	44.16	18.22	11.66
EV/EBIT Ratio	-	-	67.70	23.07	12.62
EV/FCF Ratio	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.51	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	15.08	15.08	-	9.03	4.88	1.92
Debt / FCF Ratio	-	-	-	7.91	5.97	2.05
Asset Turnover	0.69	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.63	0.63	0.51	0.50	0.87	1.26
Quick Ratio	3.02	3.02	3.28	3.90	4.69	3.09
Current Ratio	3.78	3.78	4.06	4.65	5.33	3.43
Return on Equity (ROE)	-5.00%	-5.00%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	-1.25%	-1.25%	-3.06%	1.57%	3.68%	14.13%
Return on Capital (ROIC)	-1.49%	-1.49%	-3.57%	1.79%	4.29%	18.30%
Return on Capital Employed (ROCE)	-	-	-	2.80%	6.80%	22.30%
Earnings Yield	-1.84%	-1.70%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	-0.43%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	-4.90%	-4.90%	7.09%	-0.85%	-2.70%	-1.37%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q